PriceTracker GLP-1
Loading the index…

Try

Loading the index…

Try

GLP-1 TV · Clinician · views checked Oct 2026

9 months of mounjaro... a personal update

ClinicianDr Emma Anders39,430 views15:09Aug 2025

Our summary

Dr Emma Anders, who describes herself as a doctor, gives a personal update on her time taking Mounjaro and answers viewer questions. She says she has been on 2.5 milligrams since October 2024, apart from a break from February to April, and has never raised the dose. She reports that maintenance has not been harder than losing weight for her. She says she has deliberately taken a break from dieting for a couple of months to see what her eating defaults to, and that her weight has stayed static while her running has improved and her clothes size has dropped.

General education as published by the channel. Not medical advice, and not an endorsement.

What else the video covers

She talks at length about taking up running in April, going from struggling through a 5 km park run to cutting her 10K time from over an hour and a half to just over an hour in 3 months. On side effects, she says she has had none, including no gastrointestinal effects and no hair loss, and little loose skin after losing about five stone. She says she has no plan to stop Mounjaro, comparing obesity to type 2 diabetes as a chronic condition.

She describes benefits beyond weight loss: her rosacea cleared within two to three weeks, she feels clearer mentally, and she says she saves money overall. She also explains how she handles negative reactions from others, and opens the video by recommending two books, The Ampic Revolution by Dr. Alexandra Soa and The Magic Pill by Johan Hari. All of this is her personal experience, not medical advice.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 She recommends two books for people interested in GLP-1s and obesity: one by a board-certified obesity medicine doctor and one by Johan Hari.
  2. 1:31 She says she has stayed on Mounjaro 2.5 milligrams since October 2024 apart from a break from February to April, and has not found maintenance harder than weight loss.
  3. 5:02 She describes starting running in April and cutting her 10K time from over an hour and a half to just over an hour in 3 months.
  4. 8:06 She reports no side effects, including no gastrointestinal problems and no hair loss, and little loose skin after losing about five stone.
  5. 10:16 She says she has no plans to stop Mounjaro and compares obesity to type 2 diabetes as a chronic condition.
  6. 10:36 She credits Mounjaro with clearing her rosacea within two to three weeks, improving mental clarity, and saving her money overall.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 Recommended books
  2. 1:33 My GLP-1 journey
  3. 2:27 Maintenance and mindset
  4. 5:22 Running as a new hobby
  5. 7:06 Medication effects
  6. 8:46 Hair and skin update
  7. 10:02 Long-term plans
  8. 10:55 Surprising benefits

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Mounjaro
Doses mentioned
2.5 mg
Point in the journey
Month 9
Side effects mentioned
dizziness and loose skin or face changes
Who is speaking
Clinician (Dr Emma Anders)

Questions this video answers

What dose of Mounjaro does Dr Emma Anders take?

She says she has taken 2.5 milligrams since October 2024, with a break from February to April. She says she has never increased the dose because she kept losing weight and later maintained on the same dose.

Did Mounjaro cause hair loss or side effects for her?

She says she has had no side effects at all, including no burping, vomiting, diarrhea, constipation or nausea, and no hair loss. She explains that hair loss on these drugs may come from not eating enough or from a shock to the body, and says there is no evidence yet that the drugs cause it directly.

What benefits did she notice on Mounjaro besides weight loss?

She says her severe rosacea cleared within two to three weeks and has not returned, and that her brain fog lifted and her executive function improved. She also says her mood is better and that she saves money overall.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

About Dr Emma Anders

Clinician, 68.7K subscribers. 12 of their videos are in GLP-1 TV, 1.5M views between them, mostly on Mounjaro, Ozempic, Wegovy.

Every Dr Emma Anders video

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

  • Mounjaro dosage chart: the label's schedule, every pen and vial, and what each dose costs

    Mounjaro starts at 2.5 mg injected once a week. If more blood sugar control is needed, the dose goes up in 2.5 mg steps after at least four weeks on the current dose, to a maximum of 15 mg a week for adults and 10 mg for children 10 and older. Lilly sells every strength self-pay starting at $499 a month, so on the brand the price does not climb with the dose.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

Find more like it

Side effectsDose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsMood and mental healthExercise and strengthStopping and maintenanceDizzinessLoose skin or face changes

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV